Urologix, Inc. Stock
Stocks
ULGX
US9172731047
Mining Support Services & Equipment
OTC Markets Traded|
Delayed
OTC Markets
15:48:55 2026-09-08 EDT
|
5-day change | 1st Jan Change | ||
| 0.000100 USD | 0.00% |
|
0.00% | - |
| 16-02-01 | A unknown buyer acquired substantially all of the operating assets of Urologix, Inc. | CI |
| 15-07-09 | Urologix Conducting A Strategic Review | CI |
| Market Cap | 2.13M 1.87M 1.78M 1.6M 3.02M 204M 3.06M 21.24M 8.18M 104M 7.99M 7.82M 334M | P/E 2013 |
-0.8x | P/E 2014 | -0.49x |
|---|---|---|---|---|---|
| Enterprise Value | 6.74M 5.94M 5.63M 5.08M 9.57M 647M 9.7M 67.31M 25.9M 331M 25.32M 24.77M 1.06B | EV / Sales 2013 |
0.4x | EV / Sales 2014 | 0.59x |
| Free-Float |
100% | Yield 2013 * |
-
| Yield 2014 | - |
| 1 month | 0 | 0 | |
| Current year | 0 | 0.02 | |
| 1 year | 0 | 0.02 | |
| 3 years | 0 | 0.04 | |
| 5 years | 0 | 0.04 | |
| 10 years | 0 | 0.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
Scott Madson
DFI | Director of Finance/CFO | 65 | 2015-03-31 |
Lisa Ackermann
SAM | Sales & Marketing | 53 | 2011-06-15 |
| Director | Title | Age | Since |
|---|---|---|---|
Mitchell Dann
CHM | Chairman | 65 | 1991-05-28 |
Sidney Emery
BRD | Director/Board Member | 76 | 2005-10-02 |
| Director/Board Member | 59 | 2010-08-05 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | 0.00% | 0.00% | 0.00% | 2.13K | ||
| -0.71% | -2.01% | +43.54% | +87.34% | 47.4B | ||
| -0.10% | -3.47% | +7.88% | +94.98% | 6.73B | ||
| -1.98% | -2.99% | +27.47% | +86.27% | 4.68B | ||
| -0.82% | +0.54% | +7.58% | -31.79% | 3.57B | ||
| +2.77% | -2.20% | -46.60% | +2.06% | 3.26B | ||
| +3.19% | -2.18% | -34.69% | +24.88% | 3.03B | ||
| -3.30% | -4.65% | -25.18% | +1,491.61% | 2.98B | ||
| +2.08% | +0.82% | -17.37% | -9.76% | 2.96B | ||
| -4.90% | -20.57% | +54.33% | +353.85% | 2.56B | ||
| Average | -0.38% | -4.10% | +1.70% | +209.94% | 7.72B | |
| Weighted average by Cap. | -0.57% | -2.70% | +26.29% | +135.72% |
| 2013 | 2014 | |
|---|---|---|
| Net sales | 16.48M 14.52M 13.75M 12.42M 23.4M 1.58B 23.7M 165M 63.32M 808M 61.9M 60.55M 2.59B | 14.01M 12.34M 11.69M 10.55M 19.89M 1.34B 20.15M 140M 53.83M 687M 52.62M 51.47M 2.2B |
| Net income | -4.29M -3.78M -3.58M -3.23M -6.09M -412M -6.17M -42.84M -16.49M -210M -16.12M -15.76M -674M | -7.61M -6.7M -6.35M -5.73M -10.8M -729M -10.94M -75.95M -29.23M -373M -28.57M -27.94M -1.2B |
| Net Debt | 3.04M 2.68M 2.54M 2.29M 4.32M 292M 4.38M 30.38M 11.69M 149M 11.43M 11.18M 478M | 4.62M 4.06M 3.85M 3.48M 6.55M 442M 6.64M 46.07M 17.73M 226M 17.33M 16.95M 725M |
Employees
61
- Stock Market
- Stocks
- ULGX Stock
Select your edition
All financial news and data tailored to specific country editions
















